Tissue culture and production in permeable gels

Claim 2

A process for proliferating viable mammalian cells, said process comprising: (a) suspending said cells in an alkali metal alginate solution wherein said alkali metal alginate is selected from the group consisting of low viscosity gels having a viscosity of about 50 centipoises in a 1% solution to about 250 centipoises in a 2% solution and high viscosity gels having a viscosity of about 400 centipoises in a 1% solution to about 3500 centipoises in a 2% solution at 25° C.; (b) forming the suspension into droplets; (c) gelling said droplets to form shape-retaining structures about said cells; (d) placing said cell containing structures in a growth medium which promotes proliferation of said cells; and (e) growing said cells to concentrations substantially greater than obtainable by conventional cells culture technique within said structures to proliferate cells entraped therein without the additional formation of a membrane.

Claim 3

The process of claim 1, wherein said alkali metal alginate solution is from about 0.6-2.0% w/v dissolved in physiological saline.

Claim 4

The process of claim 2, wherein said alkali metal alginate is sodium alginate.

Claim 5

The process of claim 1, wherein said droplets are gelled by contacting said droplets with multivalent cation gelling agent.

Claim 6

The process of claim 4, wherein said multivalent cation gelling agent is a solution containing about 0.6-1.5% w/v of calcium chloride.

Claim 7

The process of claim 1, wherein said gelled droplets range in size from about 0.5 mm to about 2 mm in diameter.

Claim 8

The process of claim 1, wherein said mammalian cells proliferate to cell densities greater than about 5×10 6 cells/ml.

Claim 9

The process of claim 1, wherein said cells are hybridoma cells.

Claim 10

The process of claim 8, wherein said hybridoma cells proliferate to cell densities greater than about 5×10 6 cells/ml.

Claim 11

The process of claim 1, wherein said cells having been genetically modified.

Claim 12

A process for producing a substance which is produced by viable mammalian cells, said process comprising: (a) suspending said cells in an alkali metal alginate solution wherein said alkali metal alginate is selected from the group consisting of low viscosity gels having a viscosity of about 50 centipoises in a 1% solution to about 250 centipoises in a 2% solution and high viscosity gels having a viscosity of about 400 centipoises in a 1% solution to about 3500 centipoises in a 2% solution at 25° C. (b) forming the suspension into droplets; (c) gelling said droplets to form shape-retaining structures about said cells; (d) placing said encapsulated cells in a growth medium which promotes proliferation of said cells and proliferating said cells therein to concentrations substantially greater than obtainable by convention cell culture technique without the additional formation of a membrane; (e) allowing said cells to undergo metabolism invirto to produce said substance; and (f) harvesting said substance.

Claim 13

A process for producing a substance which is produced by viable mammalian cells, said process comprising: (a) suspending said cells in an alkali metal alginate solution wherein said alkali metal alginate is selected from the group consisting of low viscosity gels having a viscosity of about 50 centipoises in a 1% solution to about 250 centipoises in a 2% solution and high viscosity gels having a viscosity of about 400 centipoises in a 1% solution to about 3500 centipoises in a 2% solution at 25° C. (b) forming the suspension into droplets; (c) gelling said droplets to form shape-retaining structures about said cells; (d) placing said encapsulated cells in a growth medium which promotes proliferation of said cells and proliferating said cells therein to concentrations substantially greater than obtainable by convention cell culture technique without the additional formation of a membrane; (e) allowing said cells to undergo metabolism invirto to produce said substance; and (f) harvesting said substance.

Claim 14

The method of claim 11, wherein said cells comprise hybridoma cells.

Claim 15

The method of claim 11, wherein said alkali metal alginate is sodium alginate and said droplets are gelled by contacting said droplets with a calcium chloride solution.

Claim 16

The method of claim 11, wherein said substance is harvested from said encapsulated cells.

Claim 17

The method of claim 11, wherein said substance diffuses into and is harested from said growth medium.

Claim 18

The process of claim 11, wherein said cells have been genetically modified.

Claim 19

The process of claim 11, wherein said gelled droplets range in size from about 0.6 mm to about 2 mm in diameter.